Skip to main content

Farxiga

Pronunciation: FAR-SEE-GUH
Generic name: dapagliflozin
Dosage form: oral tablets
Drug class: SGLT-2 inhibitors

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 2, 2024.

What is Farxiga?

Farxiga (dapagliflozin) is an oral medication that may be given to certain people with diabetes, heart disease, or kidney disease to improve their outcomes. Specifically, Farxiga is used to:

Farxiga mechanism of action involves preventing glucose reabsorption in the kidneys, and increasing how much is excreted in the urine. Farxiga works by inhibiting sodium-glucose cotransporter 2 (SGLT2), which is present in the proximal renal tubules and reabsorbs filtered glucose. By inhibiting this, Farxiga promotes the excretion of glucose in the urine.

Farxiga also works by reducing the amount of sodium reabsorbed by the kidneys and increasing how much reaches the distal tubule. This is thought to influence several physiological functions including lowering the preload and afterload of the heart, downregulating sympathetic activity, and decreasing pressure inside the kidneys.

Farxiga first gained FDA approval on January 8, 2014. There is no Farxiga generic.

Farxiga side effects

The most common side effects of Farxiga are:

Serious side effects

Farxiga can cause the following serious side effects.

Diabetic ketoacidosis (increased ketones in your blood or urine) in people with type 1 diabetes and other ketoacidosis. Farxiga can cause ketoacidosis that can be life-threatening and may lead to death. Ketoacidosis is a serious condition that needs to be treated in a hospital. People with type 1 diabetes have a high risk of getting ketoacidosis. People with type 2 diabetes or pancreas problems also have an increased risk of getting ketoacidosis. Ketoacidosis can also happen in people who are sick, cannot eat or drink as usual, skip meals, are on a diet high in fat and low in carbohydrates (ketogenic diet), take less than the usual amount of insulin, or miss insulin doses, drink too much alcohol, have a loss of too much fluid from the body (volume depletion), or who have surgery. Ketoacidosis can happen even if your blood sugar is less than 250 mg/dL. Your healthcare provider may ask you to periodically check ketones in your urine or blood. Stop taking FARXIGA and call your healthcare provider or get medical help right away if you get any of the following:

If possible, check for ketones in your urine or blood, even if your blood sugar is less than 250 mg/dL.

Dehydration. Farxiga can cause some people to become dehydrated (the loss of body water and salt). Dehydration may cause you to feel dizzy, faint, lightheaded, or weak, especially when you stand up (orthostatic hypotension). There have been reports of sudden kidney injury in people with Type 2 diabetes who are taking Farxiga. You may be at a higher risk of dehydration if you:

Talk to your healthcare provider about what you can do to prevent dehydration including how much fluid you should drink daily. Call your healthcare provider right away if you reduce the amount of food or liquid you drink, for example, if you cannot eat or you start to lose liquid from your body, for example from vomiting, diarrhea, or being in the sun too long.

Vaginal yeast infections. Women who take Farxiga may get vaginal yeast infections. Symptoms of a vaginal yeast infection include:

Yeast infection of the penis (balanitis). Swelling of an uncircumcised penis may develop in men who take Farxiga which makes it difficult to pull back the skin around the tip of the penis. Other symptoms of yeast infection of the penis include:

Allergic reactions. Farxiga may cause an allergic reaction. Do not take Farxiga if you have a history of serious hypersensitivity reactions to dapagliflozin, Farxiga, or any of the inactive ingredients in the tablets. Serious reactions, including anaphylaxis and angioedema, have been reported.

Farxiga should not be used in patients with type 1 diabetes to improve blood sugar control because it may increase their risk of diabetic ketoacidosis.

Not recommended to improve blood sugar control in people with type 2 diabetes with moderate to severe kidney disease (an eGFR of less than 45 mL/min/1.73 m2) (likely to be ineffective in this setting).

Dosages of insulin or other medications that increase insulin release may need reducing to avoid the risk of hypoglycemia. Farxiga may increase the risk of hypoglycemia developing when combined with these medications.

Serious, life-threatening cases of necrotizing fasciitis of the perineum (Fournier’s Gangrene) have been reported in patients with diabetes prescribed Farxiga. If you develop pain or tenderness, redness, or swelling in your genital or perineal area, along with fever or malaise, see your doctor immediately.

Some side effects may be more likely to occur in older adults.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before taking this medicine

You should not use Farxiga if you are allergic to dapagliflozin, or if you have:

To make sure Farxiga is safe for you, tell your doctor if you:

Pregnancy

Farxiga may cause harm to an unborn baby, especially the developing kidneys of an unborn baby. If you become pregnant while taking Farxiga, your healthcare provider may switch you to a different medicine to control your blood sugar. Talk to your healthcare provider about the best way to control your blood
sugar if you plan to become pregnant or while you are pregnant.

Breastfeeding

It is not known if Farxiga passes into your breast milk. You should not breastfeed if you take Farxiga.

How should I take Farxiga?

Take Farxiga exactly as your doctor prescribed. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

Your blood sugar will need to be checked often, and you may also need to test the level of ketones in your urine. Farxiga can cause life-threatening ketoacidosis. Even if your blood sugar is normal, contact your doctor if a urine test shows that you have high ketones in the urine.

During prolonged illness, you may become dehydrated. Call your doctor if you are sick with vomiting or diarrhea or if you eat or drink less than usual.

Farxiga dosing information

Patients should be well hydrated before starting treatment with Farxiga.

Recommended Farxiga dose for adults and children aged 10 and older for Type 2 diabetes to improve blood sugar control

Usual adult dose of Farxiga for heart failure and kidney disease

Should Farxiga be stopped for surgery?

The Farxiga Package Insert recommends withholding Farxiga for at least 3 days, if possible, before major surgery or procedures associated with prolonged fasting. Farxiga should be restarted once the person is clinically stable and has started eating or receiving nutrition again.

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Farxiga?

Avoid drinking alcohol.

Avoid getting up too fast from a sitting or lying position, or you may feel dizzy.

What other drugs will affect Farxiga?

Other drugs may increase or decrease the effects of Farxiga on lowering your blood sugar. Tell your doctor about all your current medicines and any you start or stop using, especially:

Farxiga will increase urinary glucose excretion and will lead to positive urine glucose tests. Use alternative ways to monitor glycemic control. It also interferes with some other laboratory assays.

This list is not complete. Other drugs may interact with dapagliflozin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Farxiga and Medicare

Because of the prescription drug law, known as the Inflation Reduction Act, Medicare can negotiate directly with drug companies to improve access to some of the costliest single-source brand-name Medicare Part B and Part D drugs.

Farxiga is one of 10 drugs covered under Medicare Part D that were selected in 2024 for the first cycle of negotiation based on Total Expenditures under Part D and other criteria as required by the law. Negotiations with participating drug companies are ongoing, and any negotiated prices for the first cycle of negotiation is effective from 2026.

Storage

Store at room temperature 20°C to 25°C (68°F to 77°F) away from moisture and heat. Excursions are permitted between 15°C and 30°C (59°F and 86°F).

Farxiga ingredients

Available as Farxiga 5 mg and Farxiga 10 mg tablets.

Who makes Farxiga?

AstraZeneca Pharmaceuticals LP. makes Farxiga.

Popular FAQ

Does it cause weight loss?

Farxiga may lead to modest weight loss, even though it's not a weight loss drug. Clinical studies showed people taking Farxiga alone, at either 5 mg or 10 mg daily, lost about 6 pounds over 24 weeks. Continue reading

How long does it take for Farxiga to work?

Farxiga (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is used for the treatment of type 2 diabetes, heart failure and chronic kidney disease (CKD). It starts working after just one dose, but it may take a week for Farxiga to take full effect. Continue reading

Can Farxiga cause kidney damage?

Farxiga (dapagliflozin) may cause acute kidney injury. Signs to watch out for include urinating less or swelling in you legs or feet. Before starting Farxiga your doctor will determine if you are at increased risk for acute kidney injury. Continue reading

What is Farxiga used for and how does it work?

Farxiga (dapagliflozin) is used to treat certain adults with type 2 diabetes mellitus, heart failure and chronic kidney disease.

Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It also works by reducing the increased activity of the sympathetic nervous system that contributes to the progression of heart failure and the increased intraglomerular pressure that contributes to CKD. Continue reading

Can it cause constipation?

Taking the drug Farxiga may lead to constipation in some people. The good news is that it doesn't seem to happen often. In studies, only around 2% of people taking Farxiga developed constipation, compared to 1.5% of people taking a placebo. Continue reading

More FAQ

View more FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.